Picture of AFT Pharmaceuticals logo

AFT — AFT Pharmaceuticals Share Price

0.000.00%
nz flag iconLast trade - 00:00
HealthcareBalancedSmall CapHigh Flyer

Momentum

Relative Strength (%)
1m+28.65%
3m+16.32%
6m-3.51%
1yr-7.87%
Volume Change (%)
10d/3m+66.13%
Price vs... (%)
52w High-25.2%
50d MA+1.34%
200d MA-7.97%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)16.36
PEG Ratio (f)1.18
EPS Growth (f)16.06%
Dividend Yield (f)1.6%
Valuation (ttm)IndustryMarket
Price to Book Value6.9
Price to Tang. Book20.99
Price to Free Cashflow45.71
Price to Sales3
EV to EBITDA19.75

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital21.99%
Return on Equity42.53%
Operating Margin15.65%

Financial Summary

Year End 31st MarUnit201820192020202120222023E2024ECAGR / Avg
Total RevenueNZ$m81.1885.13105.6113.11130.31156.38179.3613.49%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/an/a+248.27+157.89+17.09+13.06n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for AFT

Reasons why the market is watching Aft Pharmaceuticals (NZE:AFT) background image

Reasons why the market is watching Aft Pharmaceuticals (NZE:AFT)

The Aft Pharmaceuticals (NZE:AFT) share price is currently trading at 4.63. But to try and predict what the price will look like in the next 12 months and beyond, it's worth knowing its strengths and potential weaknesses. The good news...

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202331st Mar 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of AFT Pharmaceuticals EPS forecast chart

Profile Summary

AFT Pharmaceuticals Limited is a pharmaceutical distributor and developer of pharmaceutical intellectual property. The Company's segments include New Zealand, Australia, Asia and Rest of World. The Company's products include Crystaderm, Maxigesic, Coco-scalp, Maxiclear, RestoraNail and Myconail, among others. The Company's NasoSURF Nebuliser is in pilot scale production. The Company is focused on conducting clinical for Maxigesic oral dose forms. The Company is also conducting clinical trials of Maxigesic intravenous (IV). Maxigesic PE is a cold and flu variant. Its subsidiary, AFT Pharmaceuticals (AU) Pty Ltd, is engaged in distribution of pharmaceuticals in Australia. Its subsidiary, AFT Pharmaceuticals Singapore Pte Ltd, is engaged in the registration of pharmaceuticals in Singapore. Its subsidiary, AFT Pharmaceuticals (S.E. Asia) Sdn Bhd, is engaged in the distribution of pharmaceuticals in Malaysia.

Directors

Last Annual
March 31st, 2022
Last Interim
March 31st, 2022
Incorporated
September 4th, 1997
Public Since
December 22nd, 2015
No. of Shareholders
2,183
No. of Employees
94
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
nz flag iconNew Zealand Stock Exchange
Shares in Issue
104,697,260

AFT Share Price Performance

Upcoming Events for AFT

AFT Pharmaceuticals Ltd Annual Shareholders Meeting

AFT Pharmaceuticals Ltd Annual Shareholders Meeting

Half Year 2023 AFT Pharmaceuticals Ltd Earnings Release

Similar to AFT

Picture of BLIS Technologies logo

BLIS Technologies

nz flag iconNew Zealand Stock Exchange

Picture of Rua Bioscience logo

Rua Bioscience

nz flag iconNew Zealand Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email